[CLDX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -83.35%
YoY- 85.41%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 174 685 2,728 1,425 4,068 1,534 1,303 -28.49%
PBT -23,050 -16,538 -12,625 -17,239 -118,897 -34,261 -34,673 -6.57%
Tax -1,486 764 -16 5,234 -765 5,098 -2,062 -5.31%
NP -21,564 -16,538 -12,625 -17,239 -118,132 -34,261 -34,673 -7.60%
Tax Rate - - - - - - - -
Total Cost 21,738 17,223 15,353 18,664 122,200 35,795 35,976 -8.05%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -12,393.10 -2,414.31 -462.79 -1,209.75 -2,903.93 -2,233.44 -2,661.01 29.21%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.46 -0.42 -0.73 -1.40 -12.61 -4.19 -5.27 -33.38%
EPS Diluted -0.46 -0.42 -0.73 -1.40 -12.61 -4.19 -5.27 -33.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.